Jazz Pharmaceuticals plc

NASDAQ:JAZZ  
136.68
-2.45 (-1.76%)
Products, Other Pre-Announcement

Jazz Pharmaceuticals PLC - Announces $5 Billion Revenue Target For 2025

Published: 01/10/2022 12:45 GMT
Jazz Pharmaceuticals plc (JAZZ) - Jazz Pharmaceuticals Plc - Announces $5 Billion Revenue Target for 2025.
Jazz Pharmaceuticals Plc - Confirms 2021 Revenue Expected to Be Within Previously Announced Guidance Range, Exceeding $3 Billion.
Jazz Pharmaceuticals - on Track to Deliver Revenue Diversification, With at Least 65% of 2022 Net Product Revenue From Newly Launched Or Acquired Products.